You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Singapore-based molecular diagnostic company MiRxes announced Monday it has received CE marking and Provisional Authorization from the Singapore Health Sciences Authority for its multiplex SARS-CoV-2 and influenza A/B test.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.